Please contact Scott Hall at email@example.com or 202-463-5817.
India needs US whistleblower policies to stop spurious drugs
Global Innovation Policy Center @globalIPcenter 13h
The limited patentability of diagnostic inventions hinders the current and future research and development of new diagnostic technologies – like those developed to fight #COVID19. It’s patients who suffer most. https://t.co/UW23esA80O